CARRY-OVER EFFECTS IN BIOEQUIVALENCE STUDIES

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Biopharmaceutical Statistics

• Publication date

  2001-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1081/BIP-100104196PMID 11459441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design and Analysis of Bioavailability and Bioequivalence Studies

  2003cited by this paper
• Robust and realistic approaches to carry-over.

  1998cited by this paper
• GUIDANCE’ STATISTICAL PROCEDURES FOR BIOEQLW~CE STUDIES USING A STANDARD TWO-TREATMENT CROSSOVER DESIGN

  1998cited by this paper
• Is the 'simple carry-over' model useful?

  1992cited by this paper
• Experimental Designs

  1990cited by this paper
• Design and Analysis of Cross-Over Trials

  1989cited by this paper
• Cross-over trials, carry-over effects and the art of self-delusion.

  1988cited by this paper
• A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

  1987cited by this paper
• The crossover experiment for clinical trials.

  1980cited by this paper
• THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS.

  1965cited by this paper
• Planning of Experiments

  1958cited by this paper
• Experimental Designs, 2nd Edition

  1950cited by this paper

• Comparison of the Clinical Efficacy of the Anterolateral and Regular Approaches for Hip Joint Puncture: A Randomized Cross‐Over Trial

  2025cites this paper
• Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies

  2024cites this paper
• Cross‐Over Trials

  2021cites this paper
• Bioequivalence Studies

  2021cites this paper
• Effects of shiatsu on the health-related quality of life of a person with secondary progressive multiple sclerosis: A mixed methods N-of-1 trial within a whole systems research case study

  2019cites this paper
• Changes in Kidney Function Do Not Differ between Healthy Adults Consuming Higher- Compared with Lower- or Normal-Protein Diets: A Systematic Review and Meta-Analysis

  2018cites this paper
• Crossover Designs in Software Engineering Experiments: Benefits and Perils

  2016cites this paper
• Carryover negligibility and relevance in bioequivalence studies

  2015cites this paper
• Estimation of Amino Acid Requirement Adjusting for Carry-Over EffectBased on Approximate Change-Point Regression Model.

  2013cites this paper
• The effect of variability and carryover on average bioequivalence assessment: A simulation study

  2011cites this paper
• Use of Bayesian Methods for Multivariate Bioequivalence Measures

  2009cites this paper
• Statisticians and evidence – mote and beam

  2008cites this paper
• On equivalence and bioequivalence testing.

  2008cites this paper
• A survey of the likelihood approach to bioequivalence trials

  2008cites this paper
• Power to detect clinically relevant carry‐over in a series of cross‐over studies

  2006cites this paper
• Comment on ‘Carry‐over in cross‐over trials in bioequivalence: theoretical concerns and empirical evidence’. Senn S, D'Angelo G, Potvin D. Pharmaceutical Statistics 2004; 3(2): 133–142

  2005cites this paper
• Statistical aspects of bioequivalence assessment in the pharmaceutical industry.

  2003cites this paper
• Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in Parkinson's disease.

  2002cites this paper